Effect of ursodeoxycholic acid administration in patients with acute viral hepatitis: a pilot study
Authors:
- P FabrisPFP Fabris
- G TosittiGTG Tositti
- G MazzellaGMG Mazzella
- A R ZanettiAZA R Zanetti
- R NicolinRNR Nicolin
- G PellizzerGPG Pellizzer
- P BenedettiPBP Benedetti
- 1 September 1999
- journal article
- clinical trial
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 13 (9) , 1187-1193
Abstract
Background: : Ursodeoxycholic acid (UDCA) is able to improve biochemical markers of cholestasis, with a parallel decrease in transaminases, in various cholestatic liver diseases.Aim: : To evaluate the effects of UDCA administration on acute viral hepatitis‐related cholestasis and the course of acute viral hepatitis.Methods: : Seventy‐nine consecutive patients with acute viral hepatitis (HBV: 43, HCV: 11, HAV: 15, HEV: 3, Non A‐E: 7) were randomized to receive either UDCA for 3 weeks or no treatment. Liver biochemistry and serum bile acid determinations were run at weekly intervals.Results: : No significant differences were observed in mean percentage decreases in transaminases between treated and untreated patients. By contrast, cholestatic indexes decreased significantly more quickly in patients treated with UDCA than in controls, and this effect was more evident in patients with increasing alanine transaminase levels at admission. After a peak at the end of the first week of therapy, serum levels of conjugated ursodeoxycholic acid (CUDCA) showed a gradual decrease. Conjugated cholic acid (CCA) and chenodeoxycholic acid (CCDCA) showed a progressive decrease with the resolution of viral hepatitis, but no influence of UDCA administration was observed.Conclusions: : Our study demonstrates that UDCA significantly improves cholestatic indices in patients with acute viral hepatitis, but this effect does not seem to affect the course of the illness.Keywords
This publication has 32 references indexed in Scilit:
- Molecular aspects of membrane stabilization by ursodeoxycholateGastroenterology, 1993
- Conjugates of ursodeoxycholate protect against cholestasis and hepatocellular necrosis caused by more hydrophobic bile saltsGastroenterology, 1991
- Effect of chronic administration of ursodeoxycholic acid on the ileal absorption of endogenous bile acids in manHepatology, 1990
- Hepatic Expression of Class I and Class Ii Major Histocompatibility Complex Molecules in Primary Biliary Cirrhosis: Effect of Ursodeoxycholic AcidHepatology, 1990
- Bile acid-induced liver toxicity: Relation to the hydrophobic-hydrophilic balance of bile acidsMedical Hypotheses, 1986
- Influence of Hydroxylation and Conjugation of Bile Salts on Their Membrane-Damaging Properties-Studies on Isolated Hepatocytes and Lipid Membrane Vesicles†Hepatology, 1984
- National cooperative gallstone study: Nonprimate toxicology of chenodeoxycholic acidJournal of Toxicology and Environmental Health, 1982
- A Prospective Morphologic Evaluation of Hepatic Toxicity of Chenodeoxycholic Acid in Patients With Cholelithiasis: the National Cooperative Gallstone StudyHepatology, 1982
- Mechanism of CholestasisGastroenterology, 1972
- Bile Acids, Liver Injury, and Liver DiseaseArchives of internal medicine (1960), 1972